Antibiotic Prophylaxis for Elective Cesarean Section (TOAPFECSACT)
Infection of Cesarian Section Wound Following Delivery

About this trial
This is an interventional prevention trial for Infection of Cesarian Section Wound Following Delivery focused on measuring Elective Cesarean Section, Antibiotic prophylaxis, Timing of Antibiotic prophylaxis, post cesarean section infection
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing elective cesarean section with Gestational age 37 weeks or more
Exclusion Criteria:
- Fever greater than 38°C or maternal sepsis.
- Cephalosporin allergy.
- Exposure to any antibiotic agent within 1week before delivery.
- Patents having premature rupture of membranes and acute chorioamnionitis.
- Patients with chronic diseases (diabetes mellitus, renal disease and Cardiac disease).
3) Morbid obesity (BMI>30)
Sites / Locations
- Antibiotic Prophylaxis for Elective Cesarean Section
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group A ceftriaxone after cord clamping
Group B ceftriaxone before skin incision
165 patients pregnant at 37weeks or more undergoing elective cesarean section randomly distributed to receive 1 gm. ceftriaxone via l intravenous infusion single dose after cord clamping.
165 patients pregnant at 37weeks or more undergoing elective cesarean section randomly distributed to receive 1 gm. ceftriaxone vial intravenous infusion single dose 30-60 minutes before skin incision.